3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
5
Neoplasms
4
Prostatic Neoplasms
3
Oligodendroglioma
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Multiple Myeloma
2
Melanoma
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Anus Neoplasms
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Splenomegaly
1
Skin Neoplasms
1
Interventions
Pemetrexed
23
Cisplatin
19
Nivolumab
8
Gemcitabine
7
Ipilimumab
6
Carboplatin
6
pembrolizumab
4
Bevacizumab
4
tazemetostat
3
durvalumab
3
Fluorouracil
3
Drug Therapy
3
spartalizumab
2
olaparib
2
niraparib
2
budigalimab
2
belinostat
2
anetumab ravtansine
2
amatuximab
2
Vinorelbine
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
PM 01183
2
Oxaliplatin
2
Imatinib Mesylate
2
Everolimus
2
Erlotinib Hydrochloride
2
Doxorubicin
2
Cyclophosphamide
2
venetoclax
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Mesothelioma
×
Quality of Life
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled